Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 2.5 mg + 1000 mg, 5 mg + 1000 mg
Send MessageSaxagliptin XR & Metformin Tablets are a modern fixed-dose combination therapy developed for effective management of type 2 diabetes mellitus. This formulation combines Saxagliptin, a DPP-4 inhibitor that enhances incretin hormone activity, with Metformin in an extended-release (XR) form, which reduces hepatic glucose production and improves insulin sensitivity.
The synergy between these two agents provides comprehensive glycemic control by targeting multiple metabolic pathways—improving insulin secretion in a glucose-dependent manner while simultaneously decreasing insulin resistance. The extended-release Metformin component ensures gradual drug release, contributing to better tolerability and sustained glucose regulation.
Genliva Wellness LLP, Himatnagar, India, is a leading saxagliptin XR metformin tablet manufacturer India, delivering high-quality combination antidiabetic formulations for global pharmaceutical markets and contract manufacturing services.
Saxagliptin XR & Metformin Tablets combine a DPP-4 inhibitor with extended-release Metformin to provide sustained blood glucose control in type 2 diabetes mellitus. The formulation helps improve incretin activity, insulin response, and glucose metabolism throughout the day.
These tablets are prescribed for patients with type 2 diabetes mellitus requiring combination therapy for improved blood sugar management. They help maintain stable glucose levels along with diet and exercise.
Saxagliptin XR & Metformin Tablets provide dual-pathway glucose control with sustained therapeutic action and improved metabolic support for effective diabetes management.
